The cohort enrolling most AD patients (GSE32924) was further evaluated and showed a significant reduction of BLMH with induced levels of CXCL8 and GROα in patients compared to healthy lesional biopsies (Fig. 1B–D). The gene discussed is CXCL8; the disease is Alzheimer disease.